Literature DB >> 16189149

Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

F Farabegoli1, C Ceccarelli, D Santini, M Taffurelli.   

Abstract

AIMS: To investigate SOCS-2 (suppressor of cytokine signalling 2) protein expression in breast carcinoma samples in relation to biopathological parameters and survival.
METHODS: A polyclonal antibody against SOCS-2 was used to study 50 archival breast carcinoma samples, collected from 1993 to 1995. The presence of SOCS-2 protein was investigated in relation to clinical and biological parameters used in breast cancer pathology. Fluorescence in situ hybridisation (FISH) was used to study whether SOCS-2 expression was related to SOCS-2 gene copy number.
RESULTS: SOCS-2 protein was expressed in 34 of 50 breast carcinoma samples and was positively associated with low grade, low nuclear grade, and p27 protein. SOCS-2 expression was inversely related to Ki-67, cyclin A, retinoblastoma protein (pRb), and the epidermal growth factor receptor (EGFR). No relation with overall survival was demonstrated. SOCS-2 amplification was found in three samples. No relation between the number of FISH signals and SOCS-2 expression was found.
CONCLUSIONS: The significant correlation seen between SOCS-2 expression, grade, nuclear grade, p27, Ki-67, cyclin A, pRb, and EGFR labelling strongly supports the hypothesis that SOCS-2 loss might be related to cell proliferation and tumour growth in breast carcinoma. Gene copy number changes did not seem to play a role in SOCS-2 regulation and expression; other mechanisms might be involved and deserve further study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189149      PMCID: PMC1770736          DOI: 10.1136/jcp.2004.024919

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

Review 1.  Are SOCS suppressors, regulators, and degraders?

Authors:  James A Johnston
Journal:  J Leukoc Biol       Date:  2003-12-23       Impact factor: 4.962

2.  ERGDB: Estrogen Responsive Genes Database.

Authors:  Suisheng Tang; Hao Han; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 3.  SOCS: role in inflammation, allergy and homeostasis.

Authors:  Joanne Elliott; James A Johnston
Journal:  Trends Immunol       Date:  2004-08       Impact factor: 16.687

Review 4.  The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response.

Authors:  Warren S Alexander; Douglas J Hilton
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 5.  Suppressors of cytokine signalling: SOCS.

Authors:  Lykke Larsen; Carsten Röpke
Journal:  APMIS       Date:  2002-12       Impact factor: 3.205

6.  EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.

Authors:  C M LeVea; J E Reeder; R A Mooney
Journal:  Exp Cell Res       Date:  2004-07-01       Impact factor: 3.905

7.  Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation.

Authors:  Megan E Miller; Carmen Z Michaylira; James G Simmons; Denise M Ney; Elizabeth M Dahly; Joan K Heath; P Kay Lund
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

Review 8.  The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.

Authors:  D M Barnes; R R Millis; C E Gillett; K Ryder; D Skilton; I S Fentiman; R D Rubens
Journal:  Endocr Relat Cancer       Date:  2004-03       Impact factor: 5.678

9.  Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.

Authors:  Biao He; Liang You; Zhidong Xu; Julien Mazieres; Amie Y Lee; David M Jablons
Journal:  Clin Lung Cancer       Date:  2004-05       Impact factor: 4.785

10.  Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.

Authors:  N Fukushima; N Sato; F Sahin; G H Su; R H Hruban; M Goggins
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

View more
  22 in total

1.  Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.

Authors:  Stacey J Winham; Sebastian M Armasu; Mine S Cicek; Melissa C Larson; Julie M Cunningham; Kimberly R Kalli; Brooke L Fridley; Ellen L Goode
Journal:  Genet Epidemiol       Date:  2014-05-22       Impact factor: 2.135

2.  Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation.

Authors:  Victoria A Newton; Nicole M Ramocki; Brooks P Scull; James G Simmons; Kirk McNaughton; P Kay Lund
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 3.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

4.  Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.

Authors:  Manpreet S Chahal; H Teresa Ku; Zhihong Zhang; Christian M Legaspi; Angela Luo; Mandi M Hopkins; Kathryn E Meier
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

5.  Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.

Authors:  Anjali Teckchandani; George S Laszlo; Sergi Simó; Khyati Shah; Carissa Pilling; Alexander A Strait; Jonathan A Cooper
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

6.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Authors:  Walid Sasi; Wen G Jiang; Anup Sharma; Kefah Mokbel
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

7.  The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Authors:  Meiling Cui; Ji Sun; Jianjing Hou; Tao Fang; Xin Wang; Chao Ge; Fangyu Zhao; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li; Hong Li
Journal:  Tumour Biol       Date:  2016-07-28

8.  Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Xinyu Qiu; Jianyong Zheng; Xiaodong Guo; Xingchun Gao; Hui Liu; Yanyang Tu; Yongsheng Zhang
Journal:  Mol Cell Biochem       Date:  2013-03-11       Impact factor: 3.396

Review 9.  Genetics of breast cancer bone metastasis: a sequential multistep pattern.

Authors:  Hassan Fazilaty; Parvin Mehdipour
Journal:  Clin Exp Metastasis       Date:  2014-02-04       Impact factor: 5.150

Review 10.  SOCS proteins in regulation of receptor tyrosine kinase signaling.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Amilcar Flores-Morales; Lars Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2014-04-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.